Oncolytics Biotech |
Calgary, AB |
Human Reovirus Delivery |
Virogin Biotech |
Richmond, BC |
Oncolytic Virotherapy |
Regel Therapeutics |
Berkeley, CA |
AAV gene delivery |
Gritstone Bio |
Emeryville, CA |
Personalized cancer vaccines |
CG Oncology |
Irvine, CA |
Oncolytic Virus |
EpicentRx |
La Jolla, CA |
Epigenetics, Oncolytic viruses |
DiNAQOR |
Laguna Hills, CA |
Gene Therapy for Heart Conditions |
Armata Pharmaceuticals |
Los Angeles, CA |
Natural and synthetic bacteriophage-based therapies |
PrimeVax Immuno-Oncology |
Orange, CA |
Dengue Virus combined with autologous dendritic cells |
Genascence |
Palo Alto, CA |
Musculoskeletal Gene Therapies |
Achelois BioPharma |
Redwood City, CA |
Molecular Velcro Antiviral Technology |
Adverum Biotechnologies |
Redwood City, CA |
Adeno-Associated Virus Delivery, Gene Therapy |
Calidi Biotherapeutics |
San Diego, CA |
Oncolytic Viruses |
Kate Therapeutics |
San Diego, CA |
AAV-based gene therapy for muscle disease |
Oncolytics Biotech |
San Diego, CA |
Human Reovirus Delivery |
Poseida Therapeutics |
San Diego, CA |
Genome Editing Technologies |
Replay |
San Diego, CA |
HSV Vector Gene Therapies |
Siren Biotechnology |
San Francisco, CA |
AAV Immuno-Gene Therapy |
Tenaya Therapeutics |
South SF, CA |
Cardiovascular Therapeutics |
Capsida Biotherapeutics |
Thousand Oaks, CA |
AAV Gene Therapy |
InnoVec Biotherapeutics |
Beijing, China |
AAV-Based Gene Therapy |
Shenogen Pharma |
Beijing, China |
Small Molecules, Biologics, Viral |
Adlai Nortye |
Hangzhou, China |
Cancer & Metabolic Disease Treatments |
Belief BioMed |
Shanghai, China |
AAV-delivered Gene Therapies |
Daiichi Sankyo |
Shanghai, China |
Small Molecules |
HuidaGene Therapeutics |
Shanghai, China |
Gene Therapy, Gene editing platform, delivery vector platform |
Skyline Therapeutics |
Shanghai, China |
AAV Gene Therapy |
Astellas |
Shenyang, China |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
EurekaBio |
Shenzhen, China |
Lentiviral Vector Production System |
ImmVira |
Shenzhen, China |
Drug Delivery Vector Technology |
CaroGen |
Farmington, CT |
VLV-like Immunotherapy |
Valo Therapeutics |
Helsinki, Finland |
Oncolytic Virus, Peptide |
Transgene |
Illkirch-Graffenstaden, France |
Viral Vector Therapeutics, Gene Therapy |
Transgene |
Lyon, France |
Viral Vector Therapeutics, Gene Therapy |
EG 427 |
Paris, France |
Pinpoint Gene Therapy |
SparingVision |
Paris, France |
Retinal Gene Therapy Treatments |
Daiichi Sankyo |
Rueil Malmaison, France |
Small Molecules |
Abalos Therapeutics |
Düsseldorf, Germany |
Viral Immuno-Oncology Treatment |
DiNAQOR |
Hamburg, Germany |
Gene Therapy for Heart Conditions |
Daiichi Sankyo |
Munich, Germany |
Small Molecules |
ViGeneron |
Planegg, Germany |
AAV Gene Therapy |
Jaguar Gene Therapy |
Lake Forest, IL |
AAV-Based Gene Therapies |
Astellas |
Northbrook, IL |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
Astellas |
Dublin, Ireland |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
Astellas |
Killorglin, Ireland |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
BioMarin Pharmaceutical |
Ringaskiddy, Ireland |
Biologics |
Daiichi Sankyo |
Akita, Japan |
Small Molecules |
Daiichi Sankyo |
Fukoroi, Japan |
Small Molecules |
Daiichi Sankyo |
Fukushima, Japan |
Small Molecules |
Daiichi Sankyo |
Odawara, Japan |
Small Molecules |
Daiichi Sankyo |
Osaka, Japan |
Small Molecules |
Daiichi Sankyo |
Shinagawa, Japan |
Small Molecules |
Astellas |
Takahagi, Japan |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
Astellas |
Tokyo, Japan |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
Daiichi Sankyo |
Tokyo, Japan |
Small Molecules |
Modalis Therapeutics |
Tokyo, Japan |
Genome Editing Tools for Therapeutic Discovery |
Astellas |
Yaizu, Japan |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
GenKOre |
Daejeon, Korea |
Gene-editing therapies |
Bionoxx |
Seongnam-si, Korea |
Tumor-targeting Antigen |
GeneMedicine |
Seoul, Korea |
CDMO, Oncolytic Viruses |
GenKOre |
Seoul, Korea |
Gene-editing therapies |
Bionoxx |
Yangsan-si, Korea |
Tumor-targeting Antigen |
Rigvir |
Riga, Latvia |
Oncolytic Virotherapy |
Oxford Biomedica |
Bedford, MA |
CDMO, AAV manufacturing |
Aura Biosciences |
Boston, MA |
Delivery by Pseudo-Viruses |
Gritstone Bio |
Boston, MA |
Personalized cancer vaccines |
Kelonia Therapeutics |
Boston, MA |
in vivo CAR T Gene Therapy |
Prologue Medicines |
Boston, MA |
Viral-Derived Biologics |
Transgene |
Boston, MA |
Viral Vector Therapeutics, Gene Therapy |
Regel Therapeutics |
Cambridge, MA |
AAV gene delivery |
Voyager Therapeutics |
Lexington, MA |
AAV capsid Gene Therapy |
Candel Therapeutics |
Needham, MA |
Oncolytic Viral Immunotherapies for Cancer |
Modalis Therapeutics |
Waltham, MA |
Genome Editing Tools for Therapeutic Discovery |
Dyno Therapeutics |
Watertown, MA |
AAV Engineering |
Replimune |
Woburn, MA |
Oncolytic immunotherapy |
Novavax |
Gaithersburg, MD |
Virus-like Particles, Micelles |
Theriva Biologics |
Rockville, MD |
Oncolytic Virus Therapies |
Vyriad |
Rochester, MN |
Immunovirotherapy |
CLAIRIgene |
Durham, NC |
Viral Vector Gene Therapy |
VectorY |
Amsterdam, Netherlands |
Vectorized Antibodies |
Amarna Therapeutics |
Leiden, Netherlands |
Viral Gene Delivery Platform |
Astellas |
Meppel, Netherlands |
Small Molecules, ADC, Cell Therapy, Gene Therapy, Viral, Antibodies |
Daiichi Sankyo |
Basking Ridge, NJ |
Small Molecules, Biologics |
Rocket Pharmaceuticals |
Cranbury, NJ |
Gene Therapies |
Circio |
Oslo, Norway |
Immuno-oncology, Oncolytic Virus |
Codagenix |
Farmingdale, NY |
Live-attenuated vaccine design technology |
Apertura Gene Therapy |
New York, NY |
AAV vectors for Gene Therapy |
Humane Genomics |
New York, NY |
Precision-designed oncolytic viral therapies |
Turnstone Biologics |
Ottawa, ON |
Oncolytic viral immunotherapy |
Virica Biotech |
Ottawa, ON |
Viral Manufacturing Technology |
Chimeron Bio |
Philadelphia, PA |
Cancer Immunotherapy |
SparingVision |
Philadelphia, PA |
Retinal Gene Therapy Treatments |
Nuevocor |
Singapore, Singapore |
AAV-based gene therapy |
ExcellGene |
Monthey, Switzerland |
Cell line development & engineering. Protein engineering. GMP-process development (USP&DSP). |
DiNAQOR |
Schlieren, Switzerland |
Gene Therapy for Heart Conditions |
Redbiotec |
Schlieren, Switzerland |
Various Biologic Modalities |
Nanoscope Therapeutics |
Dallas, TX |
AAV-delivered opsin |
Replimune |
Abingdon, UK |
Oncolytic immunotherapy |
Sania Therapeutics |
London, UK |
CNS Treatments |
VacV Biotherapeutics |
London , UK |
Oncolytic Viruses |
IngeneOx Therapeutics |
Oxford, UK |
Precision therapies and vaccines for different cancer indications |
Oxford Biomedica |
Oxford, UK |
Gene-based Medicines |
Theolytics |
Oxford, UK |
Oncolytic Adenovirus Therapies |
Daiichi Sankyo |
Uxbridge, UK |
Small Molecules |
Icosavax |
Seattle, WA |
Vaccines, VLP |
Capsigen |
Vancouver, WA |
AAV Vectors |
Endsulin |
Madison, WI |
Genetic therapy for type 1 diabetes |